Oncoshot logo — Made to connect cancer patients, hospitals, and industry wit...

Oncoshot

Made to connect cancer patients, hospitals, and industry with real-time insights.

Founded 2018 Singapore Singapore 20 employees Seed Total: $2.90M Digital Health, Health Care +2

General Information

Company Name Oncoshot
Founded Year 2018
Location Singapore Singapore +3
Employees 20
Industries Digital Health, Health Care, Information Technology +1
Funding Stage Seed
Social

Get notified when Oncoshot moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Oncoshot

Oncoshot is a health insights exchange platform founded in 2018 in Singapore with the slogan "Made to connect cancer patients, hospitals, and industry with real-time insights." Founded by Medical Oncologist Dr Huren Sivaraj and Data Science Engineer Ruslan Enikeev, the startup leverages its proprietary clinical trial matching artificial intelligence technology to cater to the inefficiencies of cancer clinical trials. Notably, Oncoshot serves as a bridge between leading regional healthcare institutions and contract research organizations and global biotechnology and pharmaceutical companies, aiming to facilitate data-driven cancer clinical trials while accelerating enrolment into actively recruiting ones. The latest funding round on 13 October 2022 saw a $900.00K Seed Round investment from SEEDS Capital, Milltrust International Group, and Zubin Daruwalla. With a focus on Health Care and Information Technology industries, Oncoshot's innovative approach and partnerships are poised to make strides in the critical space of cancer research and healthcare delivery.

Taxonomy: clinical trials, oncology, data science, cancer care, patient empowerment, global healthcare, healthcare regulations, health data exchange, patient-centric solutions

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 3
Investor
•••• ••••
13 Oct 2022
Seed Round •••••• 1
Investor
14 Jul 2022
Seed Round •••••• 1 •••• •••• 01 Mar 2022
Seed Round •••••• - 01 Oct 2020
Angel Round •••••• - 01 Jun 2019

Oncoshot Alternatives & Competitors

Oncoshot vs

Accelerating clinical trial matching in oncology

Series A
5 employees
AI, Health Care
Oncoshot vs

Ensuring precise data quality in clinical trials, making them faster, easier, and more cost-effectiv...

Seed
AI, Health Care
Oncoshot vs
Outcomes4Me
Outcomes4Me United States

On a mission to democratize cancer patient care, one life at a time.

Unknown
33 employees
Biotechnology, Health Care

FAQ About Oncoshot

Made to connect cancer patients, hospitals, and industry with real-time insights.
Oncoshot was founded in 2018.
Oncoshot is headquartered in Singapore.
Oncoshot operates in the following industries: Digital Health, Health Care, Information Technology, Platforms.
Oncoshot has approximately 20 employees.
Oncoshot has completed 5 funding rounds, raising a total of $2.90M. The latest funding stage is Seed.
Top alternatives and competitors to Oncoshot include Deep Lens (acquired by Paradigm), Invio, Inc., Outcomes4Me, MatchTx LLC, Halo Health Systems. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Oncoshot and Deep Lens (acquired by Paradigm) are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Oncoshot and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes